NCT00022958View on ClinicalTrials.gov

Expanded Access Study of Iodine-131 Anti-B1 Antibody

NAUnknownINTERVENTIONAL
Timeline

Start Date

September 30, 1998

Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG

Iodine-131 Anti-B1 Antibody

Trial Locations (1)

Unknown

Central Recruiting Information, South San Francisco

Sponsors

Lead Sponsor

Corixa Corporation

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Corixa Corporation

INDUSTRY